.png)
Agenzia Italiana del Farmaco
home
Highlights
-
04 Sep 2024
Lists of Class A and Class H medicinal products
List of class A and H medicinal products at 15 January 2024
AIFA makes available, to healthcare professionals, a list of class A and H medicinal products dispensed by the National Health Service, sorted by active ingredient and trade name.
-
21 Aug 2024
Clinical trials concerning medicinal products
Guideline for the classification and conduct of observational studies on medicines
The Italian Medicines Agency has published the Guideline for the classification and conduct of observational studies on medicines in line with the provisions of the Ministerial Decree of 30 November 2021 - art. 6 paragraph 3, as part of the Italian legislation to comply with the requirements of Regulation (EU) no. 536/2014.
-
21 Aug 2024
Clinical trials concerning medicinal products
Guideline on regulatory simplification and elements of decentralisation for conducting clinical trials of medicines
The Italian Medicines Agency makes available the Guideline on regulatory simplification and elements of decentralisation for the purpose of conducting clinical trials of medicines in accordance with Regulation (EU) No. 536/2014.
-
02 Aug 2024
Press releases
Pharmaceutical expenditure for direct purchases
Pierluigi Russo, AIFA Scientific Technical Director: "Behind the increase of 1.1 billion in 2023 there is no inappropriateness but the use of innovative and life-saving drugs subject to prescription control".
News
02 Sep 2024
Monitoring Registers
Epatite C: aggiornamento del 2 settembre 2024 sui pazienti arruolati
28 Jun 2024
Inspections and authorisations
GMPMED Conference: registration open
01 Aug 2024
Inspections and authorisations
Simposio GCP del 6 dicembre 2024: aperte le iscrizioni
29 Aug 2024
Monitoring Registers
Hepatitis C: update of 26 August 2024 concerning enrolled patients
21 Aug 2024
Safety of medicinal products
Direct communication with healthcare professionals on Glatiramer acetato
19 Aug 2024
Access to medicinal products
Direct communication with healthcare professionals concerning a shortage of the medicinal product NovoSeven (eptacog alfa)
FarmaciLine
Questions regarding the efficacy, safety, and availability of drugs
NUMERO VERDE
Services
Interactive OsMed - The use of medicines in Italy
An interactive consultation of data on the use of medicines in Italy in the general and regional population, described in terms of expenditure, volumes, typology
